Idelalisib
Idelalisib is a small molecule inhibitor of the PI3K catalytic subunit p110δ (IC50: 2.5 nM). The selectivity for p110δ is 40- to 300-fold than p110α/β/γ.
| Catalog Number | T1894 |
| Alternative Name(s) | GS-1101 , CAL-101 |
| Research Area | Autophagy|||PI3K/Akt/mTOR signaling |
| Molecular Formula | C22H18FN7O |
| CAS# | 870281-82-6 |
| SMILES | [C@H](NC1=C2C(N=CN2)=NC=N1)(CC)C=3N(C(=O)C=4C(N3)=CC=CC4F)C5=CC=CC=C5 |
| Size | 200 mg |
| Supplier Page | https://www.targetmol.com/compound/Idelalisib |
| Additional Information | https://www.targetmol.com/datasheet/T1894 |
